News > Latest News

Walk News | Sponsor & Foundation News | News in the Parkinson's Disease Community

Study Evaluating Additional Indications for Teva’s Azilect


(February 25, 2014) – Clinical trials are evaluating the effect of Azilect (rasagiline) on mild cognitive impairment. Read more…